Haiyan Wu

10.1k total citations · 2 hit papers
168 papers, 4.8k citations indexed

About

Haiyan Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haiyan Wu has authored 168 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 53 papers in Oncology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haiyan Wu's work include Cancer Immunotherapy and Biomarkers (21 papers), Phytochemistry and Biological Activities (20 papers) and Neuroblastoma Research and Treatments (19 papers). Haiyan Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Phytochemistry and Biological Activities (20 papers) and Neuroblastoma Research and Treatments (19 papers). Haiyan Wu collaborates with scholars based in China, United States and United Kingdom. Haiyan Wu's co-authors include David R. Lynch, Alfredo Voloschin, Lauren Sansing, Marc A. Dichter, Joachim M. Baehring, Erdem Tüzün, Jaime Masjuan, Jeffrey Rossi, Myrna R. Rosenfeld and Haruo Shimazaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Haiyan Wu

156 papers receiving 4.7k citations

Hit Papers

Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor enc... 2007 2026 2013 2019 2007 2018 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiyan Wu China 33 1.7k 1.7k 1.1k 642 592 168 4.8k
Steven L. Carroll United States 35 1.4k 0.8× 960 0.6× 612 0.5× 312 0.5× 400 0.7× 105 3.8k
Brian Harding United Kingdom 46 2.8k 1.6× 806 0.5× 1.0k 0.9× 1.1k 1.7× 503 0.8× 162 6.9k
Hajime Hosoi Japan 35 3.1k 1.8× 649 0.4× 981 0.9× 341 0.5× 835 1.4× 189 5.1k
Carol J. Thiele United States 48 4.8k 2.7× 2.6k 1.5× 1.5k 1.3× 860 1.3× 727 1.2× 159 7.7k
Masaya Baba Japan 39 2.8k 1.6× 1.2k 0.7× 430 0.4× 597 0.9× 1.6k 2.6× 117 5.5k
Robert Layfield United Kingdom 44 3.7k 2.1× 957 0.6× 1.2k 1.1× 323 0.5× 267 0.5× 126 6.5k
Stefan Isenmann Germany 38 3.6k 2.0× 716 0.4× 434 0.4× 504 0.8× 198 0.3× 125 6.1k
Heidi Scrable United States 31 2.3k 1.3× 318 0.2× 1.0k 0.9× 516 0.8× 629 1.1× 51 4.6k
Wolfgang Roggendorf Germany 38 1.5k 0.8× 1.2k 0.7× 622 0.5× 142 0.2× 324 0.5× 109 4.7k
Stefan Liebner Germany 41 3.5k 2.0× 434 0.3× 976 0.9× 201 0.3× 430 0.7× 70 6.8k

Countries citing papers authored by Haiyan Wu

Since Specialization
Citations

This map shows the geographic impact of Haiyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Wu more than expected).

Fields of papers citing papers by Haiyan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Wu. The network helps show where Haiyan Wu may publish in the future.

Co-authorship network of co-authors of Haiyan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Wu. A scholar is included among the top collaborators of Haiyan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Wu. Haiyan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Haiyan, et al.. (2025). CCDC 2396479: Experimental Crystal Structure Determination. Open MIND.
2.
Wu, Haiyan, Xuting Zhang, Sainan Zhang, et al.. (2025). Integrated Transcriptomic and Metabolomic Analyses Implicate Key Genes and Metabolic Pathways in Maize Lodging Resistance. Agriculture. 15(23). 2416–2416.
3.
Tai, Yuling, Haiyan Wu, Lu Yang, et al.. (2024). Functional analysis of (E)-β-farnesene synthases involved in accumulation of (E)-β-farnesene in German chamomile (Matricaria chamomilla L.). Plant Science. 350. 112314–112314. 1 indexed citations
6.
Lin, Lei, Chunlei Zhou, Jinhong Zhu, et al.. (2023). miR‐100 rs1834306 a > G polymorphism decreases neuroblastoma risk in Chinese children. Cancer Reports. 6(10). e1875–e1875. 1 indexed citations
7.
Liu, Jiabin, Changmi Deng, Huiran Lin, et al.. (2023). Genetic variants of m7G modification genes influence neuroblastoma susceptibility. Heliyon. 10(1). e23658–e23658. 4 indexed citations
8.
Yao, Meng, et al.. (2023). Diaporthe actinidiicola : A novel species causing branch canker or dieback of fruit trees in Henan Province, China. Plant Pathology. 72(7). 1236–1246. 1 indexed citations
10.
Huang, He, Juan Liu, Haiyan Wu, Fang Liu, & Xiaoxi Zhou. (2021). Ferroptosis-associated gene SLC7A11 is upregulated in NSCLC and correlated with patient’s poor prognosis: An integrated bioinformatics analysis. SHILAP Revista de lepidopterología. 32(1). 106–116. 4 indexed citations
11.
McDermott, Ray, Emmanuel S. Antonarakis, Christopher Hoimes, et al.. (2020). KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC). European Urology Open Science. 19. e885–e886. 2 indexed citations
12.
Zhou, Chunlei, Yizhen Wang, Lili He, et al.. (2020). Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population. Molecular Therapy — Oncolytics. 20. 3–11. 6 indexed citations
13.
Wei, Min, et al.. (2020). Structure Elucidation of Two New Norlignans from Anemone vitifolia and Their Anti‐Inflammatory Activities. Chemistry & Biodiversity. 17(7). e2000184–e2000184. 8 indexed citations
14.
Carlino, Matteo S., Alexander M. Menzies, Victoria Atkinson, et al.. (2020). Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B. Clinical Cancer Research. 26(19). 5086–5091. 30 indexed citations
15.
Xiang, Jiale, Jingjing Yang, Haiyan Wu, et al.. (2020). Concurrent hearing and genetic screening in a general newborn population. Human Genetics. 139(4). 521–530. 32 indexed citations
16.
Xia, Jingbo, Haiyan Wu, Wentao Peng, et al.. (2019). Forkhead box O3 protects the heart against paraquat‐induced aging‐associated phenotypes by upregulating the expression of antioxidant enzymes. Aging Cell. 18(5). e12990–e12990. 48 indexed citations
17.
Zhou, Yin, Hong Zhu, Haiyan Wu, et al.. (2018). Diet‐Induced Paternal Obesity Impairs Cognitive Function in Offspring by Mediating Epigenetic Modifications in Spermatozoa. Obesity. 26(11). 1749–1757. 37 indexed citations
18.
Su, Yonghui, Jingbo Xia, Haiyan Wu, et al.. (2017). CpG oligodeoxynucleotide preconditioning improves cardiac function after myocardial infarction via modulation of energy metabolism and angiogenesis. Journal of Cellular Physiology. 233(5). 4245–4257. 14 indexed citations
19.
Yang, Wei, et al.. (2016). [Clinical characteristics and risk factors for recurrence of anal fistula patients].. PubMed. 19(12). 1370–1374. 11 indexed citations
20.
Flinn, Rory, Antonia Patsialou, Jeffrey Wyckoff, et al.. (2009). Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase. Cancer Research. 69(23). 8868–8876. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026